Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Benefits of Statin Prevention for CVD Outweigh Harms of Diabetes

2235024708_b9a36e37e1_zWikimedia Commons I Mykl Roventine

A new study published in The Lancet weighs the pros and cons of using statins to prevent cardiovascular disease when there is a risk of developing diabetes. The investigators looked at the results for the JUPITER trial, “assessing the 17,603 men and women without previous cardiovascular disease or diabetes who were randomly assigned to rosuvastatin 20 mg or placebo and followed up for up to 5 years.” Results showed that “for those with diabetes risk factors, a total of 134 vascular events or deaths were avoided for every 54 new cases of diabetes diagnosed.” For those without diabetes risk factors, “a total of 86 vascular events or deaths were avoided with no new cases of diabetes diagnosed.” Overall, the researchers determined the cardiovascular and mortality benefits of statin therapy exceed the diabetes hazard.

Read it in The Lancet.